These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 37892158)

  • 1. The Effects of Lipids on α-Synuclein Aggregation In Vitro.
    Ramirez J; Pancoe SX; Rhoades E; Petersson EJ
    Biomolecules; 2023 Oct; 13(10):. PubMed ID: 37892158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Mutations and Post-Translational Modifications on α-Synuclein In Vitro Aggregation.
    Pancoe SX; Wang YJ; Shimogawa M; Perez RM; Giannakoulias S; Petersson EJ
    J Mol Biol; 2022 Dec; 434(23):167859. PubMed ID: 36270580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruptive membrane interactions of alpha-synuclein aggregates.
    Iyer A; Claessens MMAE
    Biochim Biophys Acta Proteins Proteom; 2019 May; 1867(5):468-482. PubMed ID: 30315896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Lipids Interacting with α-Synuclein in the Pathogenesis of Parkinson's Disease.
    Galvagnion C
    J Parkinsons Dis; 2017; 7(3):433-450. PubMed ID: 28671142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synuclein Family Members Prevent Membrane Damage by Counteracting α-Synuclein Aggregation.
    Scheibe C; Karreman C; Schildknecht S; Leist M; Hauser K
    Biomolecules; 2021 Jul; 11(8):. PubMed ID: 34439733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Downsized and Optimised Intracellular Library-Derived Peptide Prevents Alpha-Synuclein Primary Nucleation and Toxicity Without Impacting Upon Lipid Binding.
    Meade RM; Watt KJC; Williams RJ; Mason JM
    J Mol Biol; 2021 Dec; 433(24):167323. PubMed ID: 34695381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anionic lipid vesicles have differential effects on the aggregation of early onset-associated α-synuclein missense mutants.
    Watt KJC; Meade RM; Williams RJ; Mason JM
    J Biol Chem; 2022 Dec; 298(12):102565. PubMed ID: 36208776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vesicle trafficking and lipid metabolism in synucleinopathy.
    Fanning S; Selkoe D; Dettmer U
    Acta Neuropathol; 2021 Apr; 141(4):491-510. PubMed ID: 32607605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of α-synuclein oligomers with lipid membranes.
    Musteikytė G; Jayaram AK; Xu CK; Vendruscolo M; Krainer G; Knowles TPJ
    Biochim Biophys Acta Biomembr; 2021 Apr; 1863(4):183536. PubMed ID: 33373595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The processes of α-synuclein amyloid protein complexes involved in the pathogenesis of Parkinson's disease].
    Kiskis J; Horvath I; Wittung-Stafshede P; Rocha S
    Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(8):75-81. PubMed ID: 30251982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Divergent effects of the H50Q and G51D SNCA mutations on the aggregation of α-synuclein.
    Rutherford NJ; Moore BD; Golde TE; Giasson BI
    J Neurochem; 2014 Dec; 131(6):859-67. PubMed ID: 24984882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemical properties of lipids strongly affect the kinetics of the membrane-induced aggregation of α-synuclein.
    Galvagnion C; Brown JW; Ouberai MM; Flagmeier P; Vendruscolo M; Buell AK; Sparr E; Dobson CM
    Proc Natl Acad Sci U S A; 2016 Jun; 113(26):7065-70. PubMed ID: 27298346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the effect of methionine oxidation on the interplay between α-synuclein and synaptic-like vesicles.
    Uceda AB; Frau J; Vilanova B; Adrover M
    Int J Biol Macromol; 2023 Feb; 229():92-104. PubMed ID: 36584779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the in vivo induction and transmission of α-synuclein pathology by mutant α-synuclein fibril seeds in transgenic mice.
    Rutherford NJ; Dhillon JS; Riffe CJ; Howard JK; Brooks M; Giasson BI
    Hum Mol Genet; 2017 Dec; 26(24):4906-4915. PubMed ID: 29036344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic modeling of α-synuclein aggregation in dopaminergic neuronal system indicates points of neuroprotective intervention: experimental validation with implications for Parkinson's therapy.
    Sultana Z; Paleologou KE; Al-Mansoori KM; Ardah MT; Singh N; Usmani S; Jiao H; Martin FL; Bharath MM; Vali S; El-Agnaf OM
    Neuroscience; 2011 Dec; 199():303-17. PubMed ID: 22056602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. α-synuclein-assisted oligomerization of β-amyloid (1-42).
    Chau E; Kim JR
    Arch Biochem Biophys; 2022 Mar; 717():109120. PubMed ID: 35041853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyunsaturated fatty acids induce alpha-synuclein-related pathogenic changes in neuronal cells.
    Assayag K; Yakunin E; Loeb V; Selkoe DJ; Sharon R
    Am J Pathol; 2007 Dec; 171(6):2000-11. PubMed ID: 18055555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unveiling transient protein-protein interactions that modulate inhibition of alpha-synuclein aggregation by beta-synuclein, a pre-synaptic protein that co-localizes with alpha-synuclein.
    Janowska MK; Wu KP; Baum J
    Sci Rep; 2015 Oct; 5():15164. PubMed ID: 26477939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-aggregation Effects of Phenolic Compounds on α-synuclein.
    Ono K; Tsuji M; Yamasaki TR; Pasinetti GM
    Molecules; 2020 May; 25(10):. PubMed ID: 32456274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crowded organelles, lipid accumulation, and abnormal membrane tubulation in cellular models of enhanced α-synuclein membrane interaction.
    Ericsson M; von Saucken V; Newman AJ; Doehr L; Hoesch C; Kim TE; Dettmer U
    Brain Res; 2021 May; 1758():147349. PubMed ID: 33571519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.